Cognitive Improvement in Schizophrenic Patients does not Require a Serotonergic Mechanism: Randomized Controlled Trial of Olanzapine vs Amisulpride

Michael Wagner, Boris B Quednow, Jens Westheide, Thomas E Schlaepfer, Wolfgang Maier, Kai-Uwe Kühn
  • Neuropsychopharmacology, December 2004, Springer Science + Business Media
  • DOI: 10.1038/sj.npp.1300626

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1038/sj.npp.1300626

The following have contributed to this page: Thomas E. Schlaepfer and Professor Boris B Quednow